Teva Pharmaceutical Industries Limited (NYSE:TEVA) is planning to acquire Celltrion, Inc. (KOSDAQ:A068270), people familiar with the matter said. Reports named AstraZeneca PLC (LSE:AZN) and Roche Holding AG (SWX:ROG) as also holding acquisition talks with Celltrion. Celltrion declined to comment on the reports.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,92,500 KRW | +2.01% |
|
+4.22% | -4.47% |
01/07 | S.Korean shares rise on robust data; battery, biopharma stocks jump | RE |
17/06 | Celltrion Reveals Positive Phase III Results of Rheumatoid Arthritis Drug | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,319 GBX | +0.61% | +1.77% | 25TCr | ||
276.4 CHF | +0.89% | +9.40% | 25TCr | ||
16.38 USD | -1.62% | -3.53% | 1.86TCr | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.47% | 2.87TCr | |
+24.74% | 4.75TCr | |
-0.47% | 4.2TCr | |
+48.83% | 4.16TCr | |
+25.40% | 3.04TCr | |
+17.96% | 2.76TCr | |
+50.73% | 1.47TCr | |
+42.56% | 1.35TCr | |
+1.46% | 1.23TCr | |
-5.60% | 1.15TCr |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Teva Reportedly In Talks To Buy Celltrion